What is the typical dose of nystatin powder for a 79-year-old female?

Nystatin Powder Dosing for 79-Year-Old Female

For a 79-year-old female, nystatin is typically dosed based on the specific indication and formulation, with oral suspension at 4-6 mL (400,000-600,000 units) four times daily or pastilles at 1-2 tablets (200,000-400,000 units) four times daily for 7-14 days for mild oropharyngeal candidiasis. 1

Dosing by Indication and Formulation

Oropharyngeal Candidiasis (Thrush)

For mild disease:

• Nystatin suspension (100,000 U/mL): 4-6 mL four times daily for 7-14 days 1
• Nystatin pastilles: 1-2 pastilles (200,000 U each) four times daily for 7-14 days 1

The IDSA 2016 guidelines provide strong recommendations with moderate-quality evidence for these regimens as alternatives to first-line azole therapy in mild oropharyngeal candidiasis.

Important considerations:

• Nystatin is considered an alternative agent, not first-line therapy for oropharyngeal candidiasis
• For moderate to severe disease, oral fluconazole 100-200 mg daily is preferred over nystatin 1
• The suspension should be swished in the mouth and retained as long as possible before swallowing
• Pastilles should be dissolved slowly in the mouth, not chewed or swallowed whole

Vulvovaginal Candidiasis

For C. glabrata infections unresponsive to azoles:

• Nystatin intravaginal suppositories: 100,000 units daily for 14 days 1

This represents a strong recommendation with low-quality evidence specifically for azole-resistant C. glabrata vulvovaginitis.

Age-Related Considerations

For this 79-year-old patient, no dose adjustment is required based on age alone. However, consider:

• Denture-related candidiasis: If present, denture disinfection must accompany antifungal therapy 1
• Medication adherence: The four-times-daily dosing may be challenging; ensure patient can comply with the regimen
• Taste issues: Poor taste is the most common adverse effect and may affect adherence in elderly patients 2
• Polypharmacy: Nystatin has minimal drug interactions due to negligible systemic absorption, making it safer in patients on multiple medications

Clinical Efficacy Context

Key evidence limitations:

• Nystatin suspension was not superior to fluconazole in treating oral candidiasis in various patient populations 2
• Nystatin pastilles were significantly superior to placebo for denture stomatitis 2
• Combination therapy (suspension + pastilles) may achieve higher cure rates than suspension alone 2
• Treatment duration of 4 weeks may be more effective than 2 weeks for some patients 2

Common Pitfalls to Avoid

1. Inadequate duration: Ensure full 7-14 day course even if symptoms resolve earlier
2. Improper administration: Patient must retain suspension in mouth or allow pastille to dissolve slowly
3. Sugar content: Some formulations contain sugar; consider sugar-free alternatives in diabetic patients 3
4. Alcohol content: FDA-labeled formulations contain 0.5-1% alcohol 4; consider in patients with alcohol sensitivity
5. Using nystatin for systemic infections: Nystatin is only effective for superficial mucosal infections due to negligible systemic absorption 5

When Nystatin is Inappropriate

Switch to systemic therapy (fluconazole) if:

• Moderate to severe oropharyngeal candidiasis 1
• Esophageal candidiasis (systemic therapy always required) 1
• Immunocompromised patients with severe disease 5
• Failure to respond after 7-14 days of nystatin therapy

The evidence strongly suggests that while nystatin remains an option for mild superficial candidiasis, fluconazole is generally more effective and better tolerated for most indications in elderly patients.